Live from the NIH registry
Studies recruiting near Indio right now
Top 25 of 73 recruiting studies, sorted by proximity — each links to its official registry page
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Novo Nordisk A/S
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Analog Device, Inc.
Study of Personalized Cancer Therapy to Determine Response and Toxicity
Cancer
N/A
Observational 10,000 participants sought
Eisenhower Medical Center, Lucy Curci Cancer Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Shu Mei Kato
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 3
Interventional 40 participants sought
GC2402 Study Site 104 — Rancho Mirage, California (10.2 mi)
· Sponsor: Grifols Therapeutics LLC
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 2
Interventional 162 participants sought
Site Number - 1607 — Rancho Mirage, California (10.2 mi)
· Sponsor: Immunovant Sciences GmbH
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Idiopathic Pulmonary Fibrosis
Phase 3
Interventional 306 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Trevi Therapeutics
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Phase 3
Interventional 2,001 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Desert Retina Consultants — Palm Desert, California (8.2 mi)
· Sponsor: Regeneron Pharmaceuticals
Shield Post-Approval Study Protocol
Colo-rectal Cancer
N/A
Observational 3,375 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Guardant Health, Inc.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Comprehensive Cancer Center at Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Agendia
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: GT Medical Technologies, Inc.
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Intracerebral Hemorrhage, Atrial Fibrillation
Phase 3
Interventional 700 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Yale University
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Palm Springs, California (19.0 mi)
· Sponsor: ViiV Healthcare
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
Soft Tissue Lesion
N/A
Observational 1,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Galvanize Therapeutics, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Palm Springs, CA — Palm Springs, California (19.0 mi)
· Sponsor: Mediar Therapeutics
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
Eisenhower Medical Center /ID# 233189 — Rancho Mirage, California (10.2 mi)
· Sponsor: AbbVie
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Phase 3
Interventional 160 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
Phase I Human Analytics (HALO) Study
Cardiovascular Diseases, Cancer
N/A
Observational 2,000 participants sought
Desert Medical Imaging — Indian Wells, California (6.3 mi)
· Sponsor: HALO Diagnostics
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network